SlideShare a Scribd company logo
Chronic renal failure –
customizing fluid
therapy.
Dr. Pallavi Ahluwalia.
1
Criteria for definition of Chronic Kidney
Disease
1. kidney damage for 3 months or more, as defined by structural
or functional abnormalities of kidney with or without
decreased GFR manifested by either
• Pathological abnormalities
• Markers of kidney damage, including abnormalities of blood
or urine abnormalities in imaging tests.
2. GFR <60ml/min/1.73 m²for≥ 3 month with or without kidney
damage.
2
STAGES OF CK D
Modified from National Kidney Foundation. K/DOQI Clinical Practice Guidelines
for Chronic Kidney Disease:evaluation,classification and stratification. Am J
Kidney Dis 39:suppl 1, 2002 .
3
Glomerular dysfunction
Tubular dysfunction
4
5
6
Chronic kidney disease
Sodium and
water
balance
Potassium
balance
Elimination
of
nitrogeneous
wastes
Erythropoietin
production
Acid-base
balance
Activation of
vitamin D
Phosphate
elimination
Skeletal
buffering
Hypocalcemia
Hyperparathyroidim
Acidosis
Osteodystrophies
Uremia
Coagulopathies
Bleeding
Heart Failure
Edema
Impaired
immune function
Skin
disorders
Gastrointestinal
manifestations
Neurologic
manifestations
Sexual
dsyfunction
Hypertension
Increased
vascular volume
CKD stage & Complications
Anemia
Electrolyte abnormalities
Metabolic acidosis
Cardiovascular complications
Volume over load
7
Preoperative assessment
CKD - Stage
Comorbidities
Investigations
Surgical procedure
Preop dialysis
8
Investigations & Diagnostic tools
• CBC - Anaemia
• BT &CT (Particularly neuroaxial anaesthesia)
• BUN (10-20 mg/dl)
• S.Creatinine (0.6-1.3 mg/dl)
• Creatinine clearance(110- 150 mg/dl)
• Blood sugar level
• Serum electrolytes(hyper kalemia)
• Urine analysis
• CXR ,ECG& ECHO
• ABG- metabolic acidosis,hypoxemia
• Imaging Modalities 9
Formula for calculating GFR
Goals of fluid therapy
• Prevent hypo & hyper volemia
• Prevent electrolyte abnormalities
• Prevent acidosis
• Prevent immediate post op dialysis
To avoid the progression of CKD to ESRD or
Acute on chronic renal failure.
10
Preop fluid status
Hypovolemia
Dehydration
Dialysis
Prolonged fasting
11
Fasting period
Third space loss
Maintenance
& Blood loss
Hypovolemia
&
Hypotension
Acute kidney injury
Why we need to give fluids ?
12
Fasting fluid – should we replace ?
• Even prolonged fasting – no decrease in absolute blood volume
• Modern fasting guideline – fluids upto 2 hours before surgery
13
Third space - fact or fiction?
No replacement for third space loss
Jacob M et al
Best Pract Res Clin Anaesthesiol. 2009
Third space Endothelial glycocalyx
14
Assumption Problems With Assumption
The patient is fasted preoperatively and is thus hypovolemic. BUT current fasting guidelines allow water ingestion up to 2 hours
prior to surgery. The so-called fluid deficit in elective surgery is
negligible
Insensible losses continue during surgery and must be accounted for. BUT with laparoscopic and other minimally invasive surgery there is
little insensible loss
Fluid shifts to the “third space” must be replaced. BUT it is unlikely that the “third space” exists
Blood loss must be replaced with three to four times the amount of
crystalloid.
BUT there should be an assessment of fluid responsiveness to guide
administration of fluid after blood loss
Hypotension following induction of anaesthesia is due to vasodilation,
and the vascular space must be filled.
BUT anaesthetic-induced vasodilation is better managed with
vasopressors and/or lighter anaesthesia to maintain peripheral
vascular resistance
Urine output must be taken into consideration and replaced BUT antidiuretic hormone excretion (ADH) during surgery makes
urine output as a guide very unreliable.
Even if the patient has an excessive intravascular volume, the kidneys will
regulate.
BUT the kidneys are already stressed by ADH, and it may take days
or weeks to excrete large fluid load 15
ASSUMPTIONS PROBLEMS WITH ASSUMPTIONS
PREOPERATIVE FASTING THUS
HYPOVOLEMIC
CURRENT FASTING GUIDELINES ALLOW WATER INGESTION UP TO 2 HOURS PRIOR TO
SURGERY
INSENSIBLE LOSSES CONTINUE DURING
SURGERY
LAPAROSCOPIC AND OTHER MINIMALLY INVASIVE SURGERY THERE IS LITTLE
INSENSIBLE LOSS
FLUID SHIFTS TO THE “THIRD SPACE” MUST
BE REPLACED.
IT’S UNLIKELY THAT THE “THIRD SPACE” EXISTS
BLOOD LOSS MUST BE REPLACED WITH
THREE TO FOUR TIMES THE AMOUNT OF
CRYSTALLOID
THERE SHOULD BE AN ASSESSMENT OF FLUID RESPONSIVENESS TO GUIDE
ADMINISTRATION OF FLUID AFTER BLOOD LOSS
HYPOTENSION FOLLOWING INDUCTION OF
ANAESTHESIA IS DUE TO VASODILATION,
AND THE VASCULAR SPACE MUST BE
FILLED.
ANAESTHESIA INDUCED VASODILATION IS BETTER MANAGED WITH VASOPRESSORS
URINE OUTPUT MUST BE TAKEN INTO
CONSIDERATION AND REPLACED
ANTIDIURETIC HORMONE SECRETION (ADH) DURING SURGERY MAKES URINE OUTPUT
UNRELIABLE
EVEN IF THE PATIENT HAS AN EXCESSIVE
INTRAVASCULAR VOLUME, THE KIDNEYS
WILL REGULATE THE FLUID LOAD
KIDNEYS ARE ALREADY STRESSED BY ADH, AND IT MAY TAKE DAYS OR WEEKS TO
EXCRETE LARGE FLUID LOAD
How to customize fluids ?
17
Monitoring urine output
GFR of individual
nephrons
No.of functioning
nephrons
GFR
• Essential to maintain volume and
hemodynamics
• To prevent acute on chronic renal failure
• NOT a reliable marker of renal function
18
Monitoring & Goals
High risk
Moderate
Low risk
< 180 min > 180 min Surgical time
Patient risk
HR, NIBP
Urine output
SVV, PPV
SV, CI, DO2 GDT
Restrictive
Liberal
Della Rocca et al, BMC Anesthesiol. 2014
19
20
Enhanced recovery after surgery (ERAS) protocol
Fluids targeting cardiac output – strongly recommended
Fluid management – independent predictive factor for post-op. outcome
21
Compared with the liberal fluid
approach, GDT is superior in terms of
riskof postoperative complication.
GDT is a term used to describe use of
cardiac output or similar paremeters
to peri-operatively guide I.V. Fluids &
inotropic therapy.
22
23
Parameters and measures
CLINICAL PARAMETERS PARACLINICAL PARAMETERS STATIC MEASURES DYNAMIC MEASURES
BODY WEIGHT CHANGES URINARY INDICES (UNa, FeNa,
FeUrea, sp. Gravity, osmolarity
CVP, IVC diameter Stroke volume and pulse
pressure variation
INPUT/OUTPUT BALANCE Hematological changes PAOP Aortic flow velocity and SV
BLOOD PRESSURE, HEART
RATE AND ORTHOSTASIS
Bio-electrical impedence RV-end diastolic volume PPV induced changes in IVC
diameter
URINE VOLUME Lactates, SVO2 LV- end diastolic area Micro circulation evaluation
CAPILLARY REFILL, SKIN
TURGOR
Extravascular lung water
index
Intra- aortic blood volume
index
ORGANOMEGALY Global end diastolic volume
index
PULMONARY EDEMA
25
Which fluid ?
Normal saline
Ringer’s lactate
Plasmalyte
Colloids
26
Malley et al, Transplantation Proceedings 2002
• 49 transplant centers
• 5544 kidney transplants
• Year 1999
27
Preference of IV fluids
0.9 % NS NS Based RL Others
> 90 % of patients
> 60 % of patients
< 30 % of patients
20
40
60
80
Malley et al, Transplantation Proceedings 2002
28
Avoid potassium
Malley et al, Transplantation Proceedings 2002
Reasons for the choice
29
Hyperchloremia - consequences
Afferent arteriole
constriction
Renal blood flow
GFR
Urine output
Chloride
30
• 12 healthy adult
• 2 L of NS / Plasmalyte over 1 hour(contains sodium acetate &
gluconate instead of sodium lactate)
• Cross over after 7-10 days
• Renal artery blood flow & renal cortical perfusion
• Electrolyte & ABG upto 4 hours
Chowdhury et al, Ann Surg 2012
31
Chowdhury et al, Ann Surg 2012
Sodium Potassium
Saline
Plasmalyte
Saline
Plasmalyte
32
Chowdhury et al, Ann Surg 2012
Chloride Bicarbonate
Saline
Plasmalyte
Saline
Plasmalyte
33
Anesthesia & Analgesia: 2015: 120 (1), 123–129.
Potura et al, Anesth Analg 2015
34
Serum chloride level
102
104
106
108
110
0 24030 60 90 120 180
Minutes after start of the surgery
Saline
Acetated solution
• 150 patients
• 4 ml/kg/hr
• Fluid bolus
Potura et al,
Anesth Analg 2015
35
Serum potassium
4.0
4.5
5.0
0 24030 60 90 120 180
Saline
Acetated solution
• 150 patients
• 4 ml/kg/hr
• Fluid bolus
Minutes after start of the surgery
Potura et al,
Anesth Analg 2015
36
pH
7.40
7.42
0 24030 60 90 120 180
Acetated solution
7.38
7.36
7.32
7.34
Saline
• 150 patients
• 4 ml/kg/hr
• Fluid bolus
Minutes after start of the surgery
Potura et al,
Anesth Analg 2015
37
Base excess5
0
- 5
0 24030 60 90 120 180
Saline
Acetated solution
• 150 patients
• 4 ml/kg/hr
• Fluid bolus
Minutes after start of the surgery
Potura et al,
Anesth Analg 2015
38
My experience
Ringer’s lactate
Normal saline
Plasmalyte
39
Role of colloid in renal failure
HES use
Acute kidney injury
Critical careIntraoperative use
No RCT
Avoid in CKD
40
6.88 6.67 6.6 6.52 6.37
2.2
14.8
22.8
29.9
44.2
1.4
6.2
9.8 11.6 12.6
0
5
10
15
20
25
30
35
40
45
50
Category 1 Category 2 Category 3 Category 4
Chart Title
#REF! pH K Lactate Column1
pH
Lactate
Potassium
Day 0 Day 42Day 7 Day 14 Day 21
1.4
Biochemical changes – Blood storage
41
Conclusion
No prolonged fasting
Plasmalyte
Individualized goal directed fluids
42
TMUThank you.
TMU,MORADABAD. 43
Monitoring & Goals
High risk
GFR-30-60
Moderate
GFR-60-90
Low risk
GFR-90
< 180 min > 180 min Surgical time
Patient risk
HR, NIBP
Urine output
SVV, PPV
SV, CI, DO2 GDT
Restrictive
Liberal
44

More Related Content

What's hot

Renal Replacement Therapy IN ICCU
Renal Replacement Therapy IN ICCURenal Replacement Therapy IN ICCU
Renal Replacement Therapy IN ICCU
teja bayapalli
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
HAMAD DHUHAYR
 
Continuous renal replacement therapy in the adult intensive care unit
Continuous renal replacement therapy in the adult intensive care unitContinuous renal replacement therapy in the adult intensive care unit
Continuous renal replacement therapy in the adult intensive care unit
IPMS- KMU KPK PAKISTAN
 
Rrt dr.sarmistha
Rrt dr.sarmisthaRrt dr.sarmistha
Rrt dr.sarmistha
sarmistha panigrahi
 
CRRT and AKI
CRRT and AKICRRT and AKI
CRRT and AKI
darsh 1980
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
Dr Kumar
 
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadRenal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
NephroTube - Dr.Gawad
 
Renal replacement therapy_
Renal replacement therapy_Renal replacement therapy_
Renal replacement therapy_
shashank agrawal
 
Renal replacement therapy in intensive care
Renal replacement therapy in intensive careRenal replacement therapy in intensive care
Renal replacement therapy in intensive care
Andrew Ferguson
 
Urgent Hemodialysis Sessions Impacts and Outcome
Urgent Hemodialysis Sessions Impacts and Outcome Urgent Hemodialysis Sessions Impacts and Outcome
Urgent Hemodialysis Sessions Impacts and Outcome
Omar Kamal
 
Renal replacement therapy for internists
Renal replacement therapy for internistsRenal replacement therapy for internists
Renal replacement therapy for internists
Mahidol University
 
Continuous rrt and its role in critically ill patients [autosaved]
Continuous rrt and its role in critically ill patients [autosaved]Continuous rrt and its role in critically ill patients [autosaved]
Continuous rrt and its role in critically ill patients [autosaved]
Harsh shaH
 
Crrt in aki
Crrt in akiCrrt in aki
Crrt in aki
FarragBahbah
 
Crrt dr osama elshahat 2017
Crrt dr osama elshahat  2017Crrt dr osama elshahat  2017
Crrt dr osama elshahat 2017
FarragBahbah
 
CRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. GawadCRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. Gawad
NephroTube - Dr.Gawad
 
Classical ‘renal’ indications for starting renal replacement therapy (RRT)
Classical ‘renal’ indications for starting renal replacement therapy (RRT) Classical ‘renal’ indications for starting renal replacement therapy (RRT)
Classical ‘renal’ indications for starting renal replacement therapy (RRT)
Syed Hussain
 
CRRT options in the ICU
CRRT options in the ICUCRRT options in the ICU
CRRT options in the ICU
Andrew Ferguson
 
Continuous renal replacement therapy in icu Crrt 2
 Continuous renal replacement therapy in icu Crrt  2 Continuous renal replacement therapy in icu Crrt  2
Continuous renal replacement therapy in icu Crrt 2
samirelansary
 
Continuous Renal Replacement Therapy
Continuous Renal Replacement TherapyContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Shairil Rahayu
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
Sandeep Gopinath Huilgol
 

What's hot (20)

Renal Replacement Therapy IN ICCU
Renal Replacement Therapy IN ICCURenal Replacement Therapy IN ICCU
Renal Replacement Therapy IN ICCU
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
Continuous renal replacement therapy in the adult intensive care unit
Continuous renal replacement therapy in the adult intensive care unitContinuous renal replacement therapy in the adult intensive care unit
Continuous renal replacement therapy in the adult intensive care unit
 
Rrt dr.sarmistha
Rrt dr.sarmisthaRrt dr.sarmistha
Rrt dr.sarmistha
 
CRRT and AKI
CRRT and AKICRRT and AKI
CRRT and AKI
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadRenal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
 
Renal replacement therapy_
Renal replacement therapy_Renal replacement therapy_
Renal replacement therapy_
 
Renal replacement therapy in intensive care
Renal replacement therapy in intensive careRenal replacement therapy in intensive care
Renal replacement therapy in intensive care
 
Urgent Hemodialysis Sessions Impacts and Outcome
Urgent Hemodialysis Sessions Impacts and Outcome Urgent Hemodialysis Sessions Impacts and Outcome
Urgent Hemodialysis Sessions Impacts and Outcome
 
Renal replacement therapy for internists
Renal replacement therapy for internistsRenal replacement therapy for internists
Renal replacement therapy for internists
 
Continuous rrt and its role in critically ill patients [autosaved]
Continuous rrt and its role in critically ill patients [autosaved]Continuous rrt and its role in critically ill patients [autosaved]
Continuous rrt and its role in critically ill patients [autosaved]
 
Crrt in aki
Crrt in akiCrrt in aki
Crrt in aki
 
Crrt dr osama elshahat 2017
Crrt dr osama elshahat  2017Crrt dr osama elshahat  2017
Crrt dr osama elshahat 2017
 
CRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. GawadCRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. Gawad
 
Classical ‘renal’ indications for starting renal replacement therapy (RRT)
Classical ‘renal’ indications for starting renal replacement therapy (RRT) Classical ‘renal’ indications for starting renal replacement therapy (RRT)
Classical ‘renal’ indications for starting renal replacement therapy (RRT)
 
CRRT options in the ICU
CRRT options in the ICUCRRT options in the ICU
CRRT options in the ICU
 
Continuous renal replacement therapy in icu Crrt 2
 Continuous renal replacement therapy in icu Crrt  2 Continuous renal replacement therapy in icu Crrt  2
Continuous renal replacement therapy in icu Crrt 2
 
Continuous Renal Replacement Therapy
Continuous Renal Replacement TherapyContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 

Similar to CUSTOMISING FLUIDS IN CHRONIC KIDNEY DISEASE

Dialytic support for aki
Dialytic support for akiDialytic support for aki
Dialytic support for aki
FarragBahbah
 
Dialytic support for AKI
Dialytic support for AKIDialytic support for AKI
Dialytic support for AKI
Dialytic support for AKIDialytic support for AKI
Crrt 2-sharm-el-shaikh-2017-dr.-osama-el shahat-final
Crrt 2-sharm-el-shaikh-2017-dr.-osama-el shahat-finalCrrt 2-sharm-el-shaikh-2017-dr.-osama-el shahat-final
Crrt 2-sharm-el-shaikh-2017-dr.-osama-el shahat-final
FarragBahbah
 
Perioperative fluid therapy logic & evidence
Perioperative fluid therapy logic & evidencePerioperative fluid therapy logic & evidence
Perioperative fluid therapy logic & evidence
padma puppala
 
CRRT
CRRTCRRT
Crrt sudan 2017 dr. osama el shahat
Crrt sudan 2017  dr. osama el shahatCrrt sudan 2017  dr. osama el shahat
Crrt sudan 2017 dr. osama el shahat
FarragBahbah
 
Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2
Chioma Iheme
 
Renal Replacement Therapy - ICU Guidlines
Renal Replacement  Therapy - ICU GuidlinesRenal Replacement  Therapy - ICU Guidlines
Renal Replacement Therapy - ICU Guidlines
LikhithaNalluru
 
Early Vs Late Renal Replacement Therapy
Early Vs Late Renal Replacement TherapyEarly Vs Late Renal Replacement Therapy
Early Vs Late Renal Replacement Therapy
Khushboo Gandhi
 
ACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENT
Rajee Ravindran
 
Salon b 13 kasim 15.45 17.00 yusuf savran-ing
Salon b 13 kasim 15.45 17.00 yusuf savran-ingSalon b 13 kasim 15.45 17.00 yusuf savran-ing
Salon b 13 kasim 15.45 17.00 yusuf savran-ing
tyfngnc
 
Hemodialysis in acute kidney injury
Hemodialysis in acute kidney injuryHemodialysis in acute kidney injury
Hemodialysis in acute kidney injury
Sherif Shaaban
 
UF vs diuretics in treatment of ADHF, Cardiorenal syndrome
UF vs diuretics in treatment of ADHF, Cardiorenal syndrome UF vs diuretics in treatment of ADHF, Cardiorenal syndrome
UF vs diuretics in treatment of ADHF, Cardiorenal syndrome
Mohamed E. Elrggal
 
Ascites.pptx
Ascites.pptxAscites.pptx
Ascites.pptx
reseptianIlhamsyah
 
Renal failure and renal replacement therapy
Renal failure and renal replacement  therapyRenal failure and renal replacement  therapy
Renal failure and renal replacement therapy
Ivan Luyimbazi
 
Basics of Hemodialysis & CRRT.pptx
Basics of Hemodialysis & CRRT.pptxBasics of Hemodialysis & CRRT.pptx
Basics of Hemodialysis & CRRT.pptx
Navin Vincent
 
Renal failure and renal replacement therapy
Renal failure and renal replacement  therapyRenal failure and renal replacement  therapy
Renal failure and renal replacement therapy
Ivan Luyimbazi
 
CRRT-f
CRRT-fCRRT-f
CRRT-f
GBKwak
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury
AIIMS, New Delhi, India
 

Similar to CUSTOMISING FLUIDS IN CHRONIC KIDNEY DISEASE (20)

Dialytic support for aki
Dialytic support for akiDialytic support for aki
Dialytic support for aki
 
Dialytic support for AKI
Dialytic support for AKIDialytic support for AKI
Dialytic support for AKI
 
Dialytic support for AKI
Dialytic support for AKIDialytic support for AKI
Dialytic support for AKI
 
Crrt 2-sharm-el-shaikh-2017-dr.-osama-el shahat-final
Crrt 2-sharm-el-shaikh-2017-dr.-osama-el shahat-finalCrrt 2-sharm-el-shaikh-2017-dr.-osama-el shahat-final
Crrt 2-sharm-el-shaikh-2017-dr.-osama-el shahat-final
 
Perioperative fluid therapy logic & evidence
Perioperative fluid therapy logic & evidencePerioperative fluid therapy logic & evidence
Perioperative fluid therapy logic & evidence
 
CRRT
CRRTCRRT
CRRT
 
Crrt sudan 2017 dr. osama el shahat
Crrt sudan 2017  dr. osama el shahatCrrt sudan 2017  dr. osama el shahat
Crrt sudan 2017 dr. osama el shahat
 
Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2
 
Renal Replacement Therapy - ICU Guidlines
Renal Replacement  Therapy - ICU GuidlinesRenal Replacement  Therapy - ICU Guidlines
Renal Replacement Therapy - ICU Guidlines
 
Early Vs Late Renal Replacement Therapy
Early Vs Late Renal Replacement TherapyEarly Vs Late Renal Replacement Therapy
Early Vs Late Renal Replacement Therapy
 
ACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENT
 
Salon b 13 kasim 15.45 17.00 yusuf savran-ing
Salon b 13 kasim 15.45 17.00 yusuf savran-ingSalon b 13 kasim 15.45 17.00 yusuf savran-ing
Salon b 13 kasim 15.45 17.00 yusuf savran-ing
 
Hemodialysis in acute kidney injury
Hemodialysis in acute kidney injuryHemodialysis in acute kidney injury
Hemodialysis in acute kidney injury
 
UF vs diuretics in treatment of ADHF, Cardiorenal syndrome
UF vs diuretics in treatment of ADHF, Cardiorenal syndrome UF vs diuretics in treatment of ADHF, Cardiorenal syndrome
UF vs diuretics in treatment of ADHF, Cardiorenal syndrome
 
Ascites.pptx
Ascites.pptxAscites.pptx
Ascites.pptx
 
Renal failure and renal replacement therapy
Renal failure and renal replacement  therapyRenal failure and renal replacement  therapy
Renal failure and renal replacement therapy
 
Basics of Hemodialysis & CRRT.pptx
Basics of Hemodialysis & CRRT.pptxBasics of Hemodialysis & CRRT.pptx
Basics of Hemodialysis & CRRT.pptx
 
Renal failure and renal replacement therapy
Renal failure and renal replacement  therapyRenal failure and renal replacement  therapy
Renal failure and renal replacement therapy
 
CRRT-f
CRRT-fCRRT-f
CRRT-f
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury
 

Recently uploaded

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 

Recently uploaded (20)

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 

CUSTOMISING FLUIDS IN CHRONIC KIDNEY DISEASE

  • 1. Chronic renal failure – customizing fluid therapy. Dr. Pallavi Ahluwalia. 1
  • 2. Criteria for definition of Chronic Kidney Disease 1. kidney damage for 3 months or more, as defined by structural or functional abnormalities of kidney with or without decreased GFR manifested by either • Pathological abnormalities • Markers of kidney damage, including abnormalities of blood or urine abnormalities in imaging tests. 2. GFR <60ml/min/1.73 m²for≥ 3 month with or without kidney damage. 2
  • 3. STAGES OF CK D Modified from National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease:evaluation,classification and stratification. Am J Kidney Dis 39:suppl 1, 2002 . 3
  • 5. 5
  • 6. 6 Chronic kidney disease Sodium and water balance Potassium balance Elimination of nitrogeneous wastes Erythropoietin production Acid-base balance Activation of vitamin D Phosphate elimination Skeletal buffering Hypocalcemia Hyperparathyroidim Acidosis Osteodystrophies Uremia Coagulopathies Bleeding Heart Failure Edema Impaired immune function Skin disorders Gastrointestinal manifestations Neurologic manifestations Sexual dsyfunction Hypertension Increased vascular volume
  • 7. CKD stage & Complications Anemia Electrolyte abnormalities Metabolic acidosis Cardiovascular complications Volume over load 7
  • 8. Preoperative assessment CKD - Stage Comorbidities Investigations Surgical procedure Preop dialysis 8
  • 9. Investigations & Diagnostic tools • CBC - Anaemia • BT &CT (Particularly neuroaxial anaesthesia) • BUN (10-20 mg/dl) • S.Creatinine (0.6-1.3 mg/dl) • Creatinine clearance(110- 150 mg/dl) • Blood sugar level • Serum electrolytes(hyper kalemia) • Urine analysis • CXR ,ECG& ECHO • ABG- metabolic acidosis,hypoxemia • Imaging Modalities 9 Formula for calculating GFR
  • 10. Goals of fluid therapy • Prevent hypo & hyper volemia • Prevent electrolyte abnormalities • Prevent acidosis • Prevent immediate post op dialysis To avoid the progression of CKD to ESRD or Acute on chronic renal failure. 10
  • 12. Fasting period Third space loss Maintenance & Blood loss Hypovolemia & Hypotension Acute kidney injury Why we need to give fluids ? 12
  • 13. Fasting fluid – should we replace ? • Even prolonged fasting – no decrease in absolute blood volume • Modern fasting guideline – fluids upto 2 hours before surgery 13
  • 14. Third space - fact or fiction? No replacement for third space loss Jacob M et al Best Pract Res Clin Anaesthesiol. 2009 Third space Endothelial glycocalyx 14
  • 15. Assumption Problems With Assumption The patient is fasted preoperatively and is thus hypovolemic. BUT current fasting guidelines allow water ingestion up to 2 hours prior to surgery. The so-called fluid deficit in elective surgery is negligible Insensible losses continue during surgery and must be accounted for. BUT with laparoscopic and other minimally invasive surgery there is little insensible loss Fluid shifts to the “third space” must be replaced. BUT it is unlikely that the “third space” exists Blood loss must be replaced with three to four times the amount of crystalloid. BUT there should be an assessment of fluid responsiveness to guide administration of fluid after blood loss Hypotension following induction of anaesthesia is due to vasodilation, and the vascular space must be filled. BUT anaesthetic-induced vasodilation is better managed with vasopressors and/or lighter anaesthesia to maintain peripheral vascular resistance Urine output must be taken into consideration and replaced BUT antidiuretic hormone excretion (ADH) during surgery makes urine output as a guide very unreliable. Even if the patient has an excessive intravascular volume, the kidneys will regulate. BUT the kidneys are already stressed by ADH, and it may take days or weeks to excrete large fluid load 15
  • 16. ASSUMPTIONS PROBLEMS WITH ASSUMPTIONS PREOPERATIVE FASTING THUS HYPOVOLEMIC CURRENT FASTING GUIDELINES ALLOW WATER INGESTION UP TO 2 HOURS PRIOR TO SURGERY INSENSIBLE LOSSES CONTINUE DURING SURGERY LAPAROSCOPIC AND OTHER MINIMALLY INVASIVE SURGERY THERE IS LITTLE INSENSIBLE LOSS FLUID SHIFTS TO THE “THIRD SPACE” MUST BE REPLACED. IT’S UNLIKELY THAT THE “THIRD SPACE” EXISTS BLOOD LOSS MUST BE REPLACED WITH THREE TO FOUR TIMES THE AMOUNT OF CRYSTALLOID THERE SHOULD BE AN ASSESSMENT OF FLUID RESPONSIVENESS TO GUIDE ADMINISTRATION OF FLUID AFTER BLOOD LOSS HYPOTENSION FOLLOWING INDUCTION OF ANAESTHESIA IS DUE TO VASODILATION, AND THE VASCULAR SPACE MUST BE FILLED. ANAESTHESIA INDUCED VASODILATION IS BETTER MANAGED WITH VASOPRESSORS URINE OUTPUT MUST BE TAKEN INTO CONSIDERATION AND REPLACED ANTIDIURETIC HORMONE SECRETION (ADH) DURING SURGERY MAKES URINE OUTPUT UNRELIABLE EVEN IF THE PATIENT HAS AN EXCESSIVE INTRAVASCULAR VOLUME, THE KIDNEYS WILL REGULATE THE FLUID LOAD KIDNEYS ARE ALREADY STRESSED BY ADH, AND IT MAY TAKE DAYS OR WEEKS TO EXCRETE LARGE FLUID LOAD
  • 17. How to customize fluids ? 17
  • 18. Monitoring urine output GFR of individual nephrons No.of functioning nephrons GFR • Essential to maintain volume and hemodynamics • To prevent acute on chronic renal failure • NOT a reliable marker of renal function 18
  • 19. Monitoring & Goals High risk Moderate Low risk < 180 min > 180 min Surgical time Patient risk HR, NIBP Urine output SVV, PPV SV, CI, DO2 GDT Restrictive Liberal Della Rocca et al, BMC Anesthesiol. 2014 19
  • 20. 20
  • 21. Enhanced recovery after surgery (ERAS) protocol Fluids targeting cardiac output – strongly recommended Fluid management – independent predictive factor for post-op. outcome 21
  • 22. Compared with the liberal fluid approach, GDT is superior in terms of riskof postoperative complication. GDT is a term used to describe use of cardiac output or similar paremeters to peri-operatively guide I.V. Fluids & inotropic therapy. 22
  • 24. CLINICAL PARAMETERS PARACLINICAL PARAMETERS STATIC MEASURES DYNAMIC MEASURES BODY WEIGHT CHANGES URINARY INDICES (UNa, FeNa, FeUrea, sp. Gravity, osmolarity CVP, IVC diameter Stroke volume and pulse pressure variation INPUT/OUTPUT BALANCE Hematological changes PAOP Aortic flow velocity and SV BLOOD PRESSURE, HEART RATE AND ORTHOSTASIS Bio-electrical impedence RV-end diastolic volume PPV induced changes in IVC diameter URINE VOLUME Lactates, SVO2 LV- end diastolic area Micro circulation evaluation CAPILLARY REFILL, SKIN TURGOR Extravascular lung water index Intra- aortic blood volume index ORGANOMEGALY Global end diastolic volume index PULMONARY EDEMA
  • 25. 25
  • 26. Which fluid ? Normal saline Ringer’s lactate Plasmalyte Colloids 26
  • 27. Malley et al, Transplantation Proceedings 2002 • 49 transplant centers • 5544 kidney transplants • Year 1999 27
  • 28. Preference of IV fluids 0.9 % NS NS Based RL Others > 90 % of patients > 60 % of patients < 30 % of patients 20 40 60 80 Malley et al, Transplantation Proceedings 2002 28
  • 29. Avoid potassium Malley et al, Transplantation Proceedings 2002 Reasons for the choice 29
  • 30. Hyperchloremia - consequences Afferent arteriole constriction Renal blood flow GFR Urine output Chloride 30
  • 31. • 12 healthy adult • 2 L of NS / Plasmalyte over 1 hour(contains sodium acetate & gluconate instead of sodium lactate) • Cross over after 7-10 days • Renal artery blood flow & renal cortical perfusion • Electrolyte & ABG upto 4 hours Chowdhury et al, Ann Surg 2012 31
  • 32. Chowdhury et al, Ann Surg 2012 Sodium Potassium Saline Plasmalyte Saline Plasmalyte 32
  • 33. Chowdhury et al, Ann Surg 2012 Chloride Bicarbonate Saline Plasmalyte Saline Plasmalyte 33
  • 34. Anesthesia & Analgesia: 2015: 120 (1), 123–129. Potura et al, Anesth Analg 2015 34
  • 35. Serum chloride level 102 104 106 108 110 0 24030 60 90 120 180 Minutes after start of the surgery Saline Acetated solution • 150 patients • 4 ml/kg/hr • Fluid bolus Potura et al, Anesth Analg 2015 35
  • 36. Serum potassium 4.0 4.5 5.0 0 24030 60 90 120 180 Saline Acetated solution • 150 patients • 4 ml/kg/hr • Fluid bolus Minutes after start of the surgery Potura et al, Anesth Analg 2015 36
  • 37. pH 7.40 7.42 0 24030 60 90 120 180 Acetated solution 7.38 7.36 7.32 7.34 Saline • 150 patients • 4 ml/kg/hr • Fluid bolus Minutes after start of the surgery Potura et al, Anesth Analg 2015 37
  • 38. Base excess5 0 - 5 0 24030 60 90 120 180 Saline Acetated solution • 150 patients • 4 ml/kg/hr • Fluid bolus Minutes after start of the surgery Potura et al, Anesth Analg 2015 38
  • 40. Role of colloid in renal failure HES use Acute kidney injury Critical careIntraoperative use No RCT Avoid in CKD 40
  • 41. 6.88 6.67 6.6 6.52 6.37 2.2 14.8 22.8 29.9 44.2 1.4 6.2 9.8 11.6 12.6 0 5 10 15 20 25 30 35 40 45 50 Category 1 Category 2 Category 3 Category 4 Chart Title #REF! pH K Lactate Column1 pH Lactate Potassium Day 0 Day 42Day 7 Day 14 Day 21 1.4 Biochemical changes – Blood storage 41
  • 44. Monitoring & Goals High risk GFR-30-60 Moderate GFR-60-90 Low risk GFR-90 < 180 min > 180 min Surgical time Patient risk HR, NIBP Urine output SVV, PPV SV, CI, DO2 GDT Restrictive Liberal 44